Inventor · disambiguated record
Yiyang Xu
Also filed as: XU YIYANG
19 granted patents·15 pending applications·96 citations·filing 2016–2025
93Inventor score
Files withEUREKA THERAPEUTICS INC24MEMORIAL SLOAN KETTERING CANCER CENTER3WISCONSIN ALUMNI RES FOUND3BLUEBIRD BIO INC1FIVE PRIME THERAPEUTICS INC1
Top patents by PatentIndex Score
34 records- 0195US11155615B2Anti-ROR1 antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Oct 26, 2021·13 cites·13 claims
- 0295US10822389B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·11 cites·22 claims
- 0394US10464988B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·16 cites·18 claims
- 0494US10098951B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·17 cites·46 claims
- 0592US10822413B2Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·13 cites·27 claims
- 0692US10011658B2Constructs targeting AFP peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Jul 3, 2018·14 cites·24 claims
- 0788US11421013B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Granted Aug 23, 2022·3 cites·20 claims
- 0888US11384144B2T cell receptor-like antibodies specific for a PRAME peptideMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 12, 2022·3 cites·46 claims
- 0982US11117964B2Anti-KIR3DL1 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Sep 14, 2021·4 cites·20 claims
- 1081US11613573B2Chimeric antibody/T-cell receptor constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Mar 28, 2023·1 cites·19 claims
- 1181US2024317855A1Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1279US2022348629A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1378US2025361286A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1476US11780982B2Green fabrication of polytetrafluoroethylene and expanded polytetrafluoroethylene and uses thereofWISCONSIN ALUMNI RES FOUND·Filed 2022·Granted Oct 10, 2023·0 cites·15 claims
- 1576US11447564B2Constructs specifically recognizing glypican 3 and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Sep 20, 2022·1 cites·25 claims
- 1675US11976105B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 1770US12479924B2Constructs specifically recognizing Glypican 3 and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Granted Nov 25, 2025·0 cites·27 claims
- 1869US2021277117A1Constructs targeting afp peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1965US11965021B2Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2024·0 cites·23 claims
- 2061US11339267B2Green fabrication of polytetrafluoroethylene and expanded polytetrafluoroethylene and uses thereofWISCONSIN ALUMNI RES FOUND·Filed 2020·Granted May 24, 2022·0 cites·17 claims
- 2159US12173125B2Methods of making polytetrafluoroethylene/polymer composites and uses thereofWISCONSIN ALUMNI RES FOUND·Filed 2020·Granted Dec 24, 2024·0 cites·15 claims
- 2257US2018009892A1Anti-ror1 antibodiesEUREKA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2356US11827672B2Constructs trageting CD22 and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 28, 2023·0 cites·20 claims
- 2449US2022267420A1Foxp3 targeting agent compositions and methods of use for adoptive cell therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 2549US2022237917A1Video comparison method and apparatus, computer device, and storage mediumTENCENT TECH SHENZHEN CO LTD·Filed 2022·Application pending·0 cites
- 2648US2022265715A1Chimeric antigen receptor t cells and uses thereofEUREKA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2748US2018208658A1Constructs targeting afp peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2847US2022323497A1Cells expressing chimeric antigen receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2947US2020255505A1Cells Expressing Cell Surface Receptors and AntibodiesEUREKA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3043US2020342647A1Character creation method and apparatus, storage device, and electronic deviceXU YIYANG·Filed 2019·Application pending·0 cites
- 3142US11274157B2Constructs targeting histone H3 peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Mar 15, 2022·0 cites·28 claims
- 3239US2020087400A1Constructs targeting psa peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3338US2018147271A1Anti-ror1 chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2016·Application pending·0 cites
- 3437US2019382504A1Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yiyang Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →